Snowball logo
logo
GXI_logo

Gerresheimer AG

GXI XETRA
28.02+0.42  (1.52%)
Estimate
EPS
-9.27
Beta
0.473
Forecast
P/E (FWD)
8.2
EPS (FWD)
3.41
Dividends
Dividend yield
0.14%
Annual payout
0.04
Next ex. div date
June 5, 27
Div.growth, 5y
-49.35%
Div.rating
About the company
Ticker
GXI
ISIN
DE000A0LD6E6
Country
Germany
Sector (GICS)
Healthcare
Gerresheimer AG, together with its subsidiaries, provides drug containment solutions in Germany and internationally. The company operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. It offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and containers, bottles, caps, closures, applicators, and accessories; development, industrialization, and contract manufacturing of drug delivery programs; project and quality management; and drug delivery devices, including inhalers, injection/auto injectors, and pen injectors. The company also provides diagnostic and medical devices comprising point-of-care tests, laboratory disposables, chemical and technical bottles, diagnostic and polymer vials, dropper bottles, PET bottles, and medical products comprising lancing devices, infusion sets, and disposable systems. In addition, it offers cosmetic packaging solutions, such as moulded glass flacons and jars; tubular glass ampoules, droppers, samplers and vials; and plastic packaging products, as well as pharmaceutical, laboratory, and regulatory affairs services. The company offers its products to pharmacy chains, supermarkets, and wholesalers. The company serves pharma, biotech, medical technology, diagnostics, cosmetics, glass containers, and food and beverage industries. Gerresheimer AG was founded in 1864 and is based in Düsseldorf, Germany.

Frequently asked questions

What sector does Gerresheimer AG (GXI) operate in?

Gerresheimer AG belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.

What is Gerresheimer AG (GXI) current stock price?

As of the latest data, Gerresheimer AG stock price is €28.02, with a previous close of €27.60. Gerresheimer AG gained €0.42 in the last trading session, representing a 1.52% increase.

What is Gerresheimer AG (GXI) current market capitalization?

Gerresheimer AG market cap is approximately 967.81 million.

What is Gerresheimer AG (GXI) Earnings Per Share (EPS)?

The trailing EPS is -€9.27, and the forward EPS is €3.41.

Does Gerresheimer AG (GXI) pay dividends?

Yes. Gerresheimer AG pays annual dividends with an annualized yield of 0.14% and an estimated annual payout of €0.04 per share.

When is the next ex-dividend date for Gerresheimer AG (GXI)?

The next ex-dividend date is scheduled for June 05, 2027.

What is Gerresheimer AG (GXI) beta (volatility) score?

Gerresheimer AG has a beta of 0.473, indicating lower volatility than the overall market.